Long-term safety of twice-daily aclidinium bromide in COPD patients: A one-year, double-blind study

被引：0

作者：

Gelb, Arthur ^{[1
]}

Tashkin, Donald ^{[2
]}

Make, Barry ^{[3
]}

Zhong, Xiaoyun ^{[4
]}

Gil, Esther Garcia ^{[5
]}

Caracta, Cynthia ^{[6
]}

机构：

[1] Southern Calif Clin Trials, Lakewood, CO USA

[2] UCLA, Div Pulm & Crit Care Med, David Geffen Sch Med, Los Angeles, CA USA

[3] Natl Jewish Hlth, Dept Med, Denver, CO USA

[4] Forest Res Inst, Biostat, Jersey City, NJ USA

[5] Almirall SA, R&D Ctr, Barcelona, Spain

[6] Forest Res Inst, Clin Dev, Jersey City, NJ USA

来源：

EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷

关键词：

COPD; -; management; Bronchodilators; Exacerbation;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

3536

引用

页数：1

共 50 条

[41] Novel Once-Daily Extended-Release Tacrolimus (LCPT) Versus Twice-Daily Tacrolimus in De Novo Kidney Transplants: One-Year Results of Phase III, Double-Blind, Randomized Trial
Budde, K.
Bunnapradist, S.
Grinyo, J. M.
Ciechanowski, K.
Denny, J. E.
Silva, H. T.
Rostaing, L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (12) : 2796 - 2806
[42] Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris:: Double-blind and open-label studies
Messin, R
Carreer-Bruhwyler, F
Dubois, C
Famaey, JP
Géczy, J
ADVANCES IN THERAPY, 2006, 23 (01) : 107 - 130
[43] Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: Double-blind and open-label studies
Roger Messin
Fabienne Carreer-Bruhwyler
Claude Dubois
Jean-Pierre Famaey
Joseph Géczy
Advances in Therapy, 2006, 23 : 107 - 130
[44] New Statistical Proposals to Evaluate the Benefit/Risk Ratio of Long-Term Treatment of DepressionApplication to a One-Year Double-Blind Study Comparing Medifoxamine with Fluoxetine
Philippe Lehert
M.F. Poirier-Littre
D. Pringuey
A. Galinowski
Clinical Drug Investigation, 1998, 15 : 285 - 295
[45] Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients
Frei, UA
Neumayer, HH
Buchholz, B
Niese, D
Mueller, EA
TRANSPLANTATION, 1998, 65 (11) : 1455 - 1460
[46] A DOUBLE-BLIND COMPARATIVE-STUDY OF THE ANTIHYPERTENSIVE EFFECTIVENESS OF ONCE VS TWICE-DAILY DOSING OF METHYLDOPA-HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTS
NOVECK, RJ
MCMAHON, FG
RYAN, JR
JAIN, AK
LACORTE, W
CHANGCHIEN, S
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 269 - 270
[47] Exposure-Adjusted Anticholinergic Adverse Events Following Long-term Treatment With Aclidinium Bromide in Patients With COPD
D'Urzo, Anthony
Rennard, Stephen
Jones, Paul
Rekeda, Ludmyla
Gil, Esther Garcia
Caracta, Cynthia
CHEST, 2013, 144 (04)
[48] Serevent diskus - Salmeterol xinafoate inhalation powder - GLAXOSMITHKLINE - Long-term, twice-daily treatment of bronchospasm associated with COPD
不详
FORMULARY, 2002, 37 (05) : 223 - 223
[49] A double-blind, placebo-controlled evaluation of safety and efficacy of 12-week, twice-daily treatment with prucalopride in patients with chronic constipation.
Otten, MH
Schneider, H
Wurzer, H
Tefera, S
Van Eeghem, P
Graf, W
Van't Klooster
GASTROENTEROLOGY, 1999, 116 (04) : A1055 - A1055
[50] New statistical proposals to evaluate the benefit/risk ratio of long-term treatment of depression - Application to a one-year double-blind study comparing medifoxamine with fluoxetine
Lehert, P
Poirier-Littre, MF
Pringuey, D
Galinowski, A
CLINICAL DRUG INVESTIGATION, 1998, 15 (04) : 285 - 295

← 1 2 3 4 5 →